As a company with innovative medical devices, we were selected for MedTech Innovator Asia Pacific 2022 Road Tour Program, which organizes the globalization program for innovative technology products through funding and global marketing.

In addition, we introduced the company and products to Medtech Innovator, a global medical device accelerator, and to investors around the world.

The head office of Medtech is located in the United States, and the Asia-Pacific Medtech Innovator, which selects us and organizes this event, has a head office in Singapore.

This event is a program for companies and investors with innovative medical device technology in Asia and the Pacific.

Investors in advanced countries focus on future value by discovering and investing technology to foster a global company by supporting marketing using global network as well as investment focusing on technology-oriented innovative product future value and marketability.

It is an IR program that is completely different from domestic investors who simply invest in finance and list and prioritize profits.

If the program is selected and invested, the message of symbolism and competence to domestic investors is strong, and the history of Anyfusion will be rewritten at the global level.

I would like to thank Medtech officials who highly appreciated Anyfusion technology with a high perspective.

We will do our best to prepare global investors for Anyfusion's technology, marketability, and marketability, which has been verified in the real world reference so far, so that it will be a good opportunity and advance to the U.S. with results.

Thank you.